Bhatt Padmanabh P.
SEC CIK 1539215 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | CSO, SVP of IP | 19.8K | — | $10.71M | 56 | 2022-07-15 | 2026-08-12 |
Most active insiders at SUPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| 2 | Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| 3 | NEWHALL CHARLES W III | Dir | — | $1.27M |
| 4 | Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| 5 | GEMAYEL GEORGES | Dir | — | $1.00M |
| 6 | Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| 7 | Hudson Frederick M. | Dir | — | $271.7K |
| 8 | Sensenig Bethany | Dir | — | $228.3K |
| 9 | Rubin Jonathan | SVP, Chief Medical Off | — | — |
| 10 | Barlow Carrolee | Dir | — | — |
Transactions 56
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +2,500 | 19.8K | +14% | $0 |
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $46.57 | -1,158 | 18.6K | -6% | -$53.9K |
| DM | 2026-03-18 | 2026-03-16+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $36.29 | +107.2K | 24.3K | New | +$3.89M |
| DM | 2026-03-18 | 2026-03-16+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $50.24 | -107.2K | 17.5K | -86% | -$5.39M |
| D | 2026-02-26 | 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +1,250 | 17.7K | +8% | $0 |
| D | 2026-02-26 | 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $50.69 | -650 | 17.0K | -4% | -$32.9K |
| DM | 2026-02-25 | 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +3,125 | 16.2K | +24% | $0 |
| DM | 2026-02-25 | 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $51.04 | -1,581 | 15.4K | -9% | -$80.7K |
| D | 2025-12-19 | 2025-12-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $44.44 | -710 | 14.5K | -5% | -$31.6K |
| D | 2025-12-19 | 2025-12-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,500 | 15.2K | +11% | $0 |
| D | 2025-08-27 | 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,250 | 14.3K | +10% | $0 |
| D | 2025-08-27 | 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $41.46 | -581 | 13.7K | -4% | -$24.1K |
| M | 2025-03-05 | 2025-03-05 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $33.05 | -1,485 | 13.9K | -10% | -$49.1K |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +3,250 | 12.9K | +34% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $39.15 | -860 | 10.9K | -7% | -$33.7K |
| D | 2025-02-24 | 2025-02-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,650 | 11.8K | +16% | $0 |
| D | 2025-02-05 | 2025-02-04 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $29.61 | +9,477 | 19.6K | +93% | +$280.6K |
| D | 2025-02-05 | 2025-02-04 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.70 | -9,477 | 10.1K | -48% | -$376.2K |
| DM | 2025-01-29 | 2025-01-27+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.62 | -3,273 | 10.1K | -24% | -$129.7K |
| DM | 2025-01-29 | 2025-01-27+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $29.61 | +3,273 | 10.8K | +43% | +$96.9K |
| DM | 2024-12-04 | 2024-12-03 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $36.68 | -21.5K | 9,679 | -69% | -$788.4K |
| DM | 2024-12-04 | 2024-12-03 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $24.77 | +21.5K | 18.4K | New | +$532.4K |
| D | 2024-08-20 | 2024-08-20 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $29.57 | -572 | 9,679 | -6% | -$16.9K |
| D | 2024-08-20 | 2024-08-20 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,250 | 10.3K | +14% | $0 |
| D | 2024-03-25 | 2024-03-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +14.5K | 23.1K | +169% | +$366.6K |
| D | 2024-03-25 | 2024-03-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -14.5K | 8,570 | -63% | -$511.7K |
| D | 2024-03-22 | 2024-03-20 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -400 | 8,570 | -4% | -$14.1K |
| D | 2024-03-22 | 2024-03-20 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +400 | 8,970 | +5% | +$10.1K |
| D | 2024-03-21 | 2024-03-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -12.4K | 8,570 | -59% | -$436.6K |
| D | 2024-03-21 | 2024-03-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +12.4K | 20.9K | +144% | +$312.8K |
| DM | 2024-03-15 | 2024-03-13 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $17.61 | +62.4K | 44.7K | New | +$1.10M |
| DM | 2024-03-15 | 2024-03-13 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $33.74 | -62.4K | 8,570 | -88% | -$2.10M |
| D | 2024-03-14 | 2024-03-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $12.98 | +3,884 | 12.5K | +45% | +$50.4K |
| D | 2024-03-14 | 2024-03-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $32.99 | -3,884 | 8,570 | -31% | -$128.1K |
| D | 2024-02-28 | 2024-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $30.21 | -5,000 | 8,570 | -37% | -$151.1K |
| D | 2024-02-28 | 2024-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +5,000 | 13.6K | +58% | +$45.7K |
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $29.06 | -638 | 8,570 | -7% | -$18.5K |
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +1,250 | 9,208 | +16% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $27.94 | -372 | 7,958 | -4% | -$10.4K |
| D | 2024-02-26 | 2024-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +750 | 8,330 | +10% | $0 |
| D | 2023-09-07 | 2023-09-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $32.10 | -1,182 | 7,165 | -14% | -$37.9K |
| D | 2023-09-07 | 2023-09-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +2,500 | 8,347 | +43% | $0 |
| D | 2023-05-12 | 2023-05-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +750 | 5,497 | +16% | $0 |
| 2023-04-12 | 2023-04-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +1,500 | 4,747 | +46% | $0 | |
| D | 2023-02-24 | 2023-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +750 | 3,247 | +30% | $0 |
| D | 2023-01-19 | 2023-01-17 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +4,826 | 6,470 | +294% | +$44.1K |
| D | 2023-01-19 | 2023-01-17 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.92 | -4,826 | 1,644 | -75% | -$192.7K |
| D | 2023-01-09 | 2023-01-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.90 | -174 | 1,644 | -10% | -$6,943 |
| D | 2023-01-09 | 2023-01-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +174 | 1,818 | +11% | +$1,589 |
| D | 2022-12-02 | 2022-12-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $37.48 | -5,000 | 1,644 | -75% | -$187.4K |
| D | 2022-12-02 | 2022-12-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +5,000 | 6,644 | +304% | +$45.7K |
| D | 2022-11-15 | 2022-11-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $34.95 | -6,800 | 1,644 | -81% | -$237.7K |
| D | 2022-11-15 | 2022-11-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.24 | +6,800 | 8,444 | +414% | +$62.8K |
| D | 2022-11-14 | 2022-11-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.24 | +700 | 2,344 | +43% | +$6,468 |
| D | 2022-11-14 | 2022-11-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $34.97 | -700 | 1,644 | -30% | -$24.5K |
| 2022-08-05 | 2022-07-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +750 | 1,644 | +84% | $0 |
Purchase Sale Sale after option exercise All abbreviations